Talking realistically, we have a 2.5-5 year roadmap ahead of us, with around ten major deliverables (or more, given management have said they have things that are being worked on but cannot be discussed or disclosed yet) due over the next 12 or so months.
IMO, and in the opinions of our KOLs, the drug has been sufficiently derisked and shows brilliant effecacy and addresses unmet needs, but execution remains the biggest challenge. Until we have more signs of successful execution, we will probably hover around this price point.
I think it's entirely fair to say that RAC remains a long-term investment with a lot of work to do and ground to make up. I believe it will more than meet our expectations, if people have the patience to hold.
General Comments / Chat, page-9611
-
- There are more pages in this discussion • 1,402 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |